That is no correct. As we all know medicine is not a cut and dry science......there were many criteria one had to meet other that just a Dx of COPD, and also there was consideration of exacerbation requiring Steroids, and also Eosinophil count both in blood and sputum. It is difficult to explain to people that don't work in the medical arena that there are numerous times medications are prescribed for what is called "off-label" use. In fact if you research it almost 20% of prescriptions written are for off-label use. As of July, Dupixent has been approved through the FDA for COPD patients....Dupixent has about 7 indicators that it is used for. So to date, the two new drugs that have been approved just this summer by the FDA for COPD (specifically and not off-label) are Dupixent and Ohtuvayre.